Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.09B |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$487M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$368M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$278M |
| 5 |
Vanguard Long-Term Bond ETF
BLV
|
+$261M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$271M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
| 4 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$230M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$228M |
Sector Composition
| 1 | Technology | 12.21% |
| 2 | Financials | 9.1% |
| 3 | Healthcare | 8.94% |
| 4 | Industrials | 8.37% |
| 5 | Consumer Discretionary | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSS
3026
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $2.54M | ﹤0.01% |
57,968
-1,451,981
| -96% | -$63.5M |
|
|
SLCA
3027
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.53M | ﹤0.01% |
198,147
-11,487
| -5% | -$147K |
|
|
MMU
3028
Western Asset Managed Municipals Fund
MMU
$570M
| $2.53M | ﹤0.01% |
184,797
-28,117
| -13% | -$385K |
|
3029
Kite Realty
KRG
$4.84B
| $2.53M | ﹤0.01% |
167,189
+4,989
| +3% | +$75.5K |
|
|
EFR
3030
Eaton Vance Senior Floating-Rate Fund
EFR
$342M
| $2.53M | ﹤0.01% |
192,996
-1,540
| -0.8% | -$20.2K |
|
3031
Barings BDC
BBDC
$959M
| $2.52M | ﹤0.01% |
255,689
+24,459
| +11% | +$241K |
|
3032
Abercrombie & Fitch
ANF
$4.02B
| $2.51M | ﹤0.01% |
156,785
+17,832
| +13% | +$286K |
|
3033
Chord Energy
CHRD
$6.03B
| $2.51M | ﹤0.01% |
441,115
-203,597
| -32% | -$1.16M |
|
3034
JELD-WEN Holding
JELD
$500M
| $2.5M | ﹤0.01% |
117,899
+76,455
| +184% | +$1.62M |
|
3035
TriCo Bancshares
TCBK
$1.47B
| $2.5M | ﹤0.01% |
66,054
+632
| +1% | +$23.9K |
|
3036
BGC Group
BGC
$4.59B
| $2.5M | ﹤0.01% |
476,997
+98,631
| +26% | +$516K |
|
3037
Range Resources
RRC
$8.47B
| $2.49M | ﹤0.01% |
356,462
-376,256
| -51% | -$2.63M |
|
3038
Aegon
AEG
$12.1B
| $2.49M | ﹤0.01% |
565,800
+89,138
| +19% | +$391K |
|
3039
Lifecore Biomedical
LFCR
$288M
| $2.48M | ﹤0.01% |
264,540
-9,679
| -4% | -$90.7K |
|
3040
Nuveen AMT-Free Municipal Value Fund
NUW
$253M
| $2.48M | ﹤0.01% |
146,805
-1,008
| -0.7% | -$17K |
|
3041
Ascendis Pharma
ASND
$12.1B
| $2.46M | ﹤0.01% |
21,330
-4,587
| -18% | -$528K |
|
|
FOCS
3042
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $2.45M | ﹤0.01% |
89,854
+23,906
| +36% | +$653K |
|
3043
iShares Global Comm Services ETF
IXP
$702M
| $2.45M | ﹤0.01% |
42,841
-3,920
| -8% | -$224K |
|
3044
Nuveen Municipal High Income Opportunity Fund
NMZ
$1.22B
| $2.45M | ﹤0.01% |
175,493
+16,837
| +11% | +$235K |
|
3045
BlackRock Health Sciences Trust
BME
$470M
| $2.45M | ﹤0.01% |
62,975
-7,724
| -11% | -$300K |
|
3046
Energizer
ENR
$2.02B
| $2.44M | ﹤0.01% |
63,234
+1,564
| +3% | +$60.4K |
|
|
RAVN
3047
DELISTED
Raven Industries Inc
RAVN
| $2.44M | ﹤0.01% |
68,029
-6,808
| -9% | -$244K |
|
3048
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$75.1M
| $2.43M | ﹤0.01% |
108,658
-993
| -0.9% | -$22.2K |
|
|
ARQL
3049
DELISTED
Arqule Inc
ARQL
| $2.43M | ﹤0.01% |
221,116
+32,015
| +17% | +$352K |
|
3050
Enanta Pharmaceuticals
ENTA
$161M
| $2.43M | ﹤0.01% |
28,826
+1,668
| +6% | +$141K |
|